Drug Type Small molecule drug |
Synonyms Tubocurarine chloride (USP), Tubocurarine chloride hydrate (JAN), NSC-757362 |
Target |
Mechanism 5-HT3A receptor antagonists(5-HT 3a receptor antagonists), CHRNA2 inhibitors(cholinergic receptor nicotinic alpha 2 subunit inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (28 Nov 1947), |
Regulation- |
Molecular FormulaC37H52Cl2N2O11 |
InChIKeyWMIZITXEJNQAQK-GGDSLZADSA-N |
CAS Registry6989-98-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02207 | Tubocurarine Chloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Muscle Hypotonia | US | 28 Nov 1947 |